Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.6T | 1.6T | 1.6T | 1.5T |
Cost of revenue | 522.0B | 569.5B | 583.9B | 538.2B |
Gross profit | 1.0T | 1.1T | 1.0T | 994.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 123.0B | 122.6B | 135.1B | 128.1B |
Other operating expenses | 350.9B | 319.8B | 233.7B | 202.3B |
Operating income | 498.9B | 548.9B | 590.6B | 590.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 44.5B | 48.9B | 51.9B | 46.0B |
Other income expense | — | — | — | — |
Pretax income | 441.6B | 499.4B | 553.5B | 528.6B |
Tax provision | 84.9B | 93.9B | 103.7B | 99.5B |
Net income | 356.7B | 405.5B | 449.8B | 429.1B |
Basic EPS | — | 27 | — | — |
Diluted EPS | — | 27 | — | — |
Basic average shares | — | 15.0B | — | — |
Diluted average shares | — | 15.0B | — | — |
EBITDA | 551.9B | 602.9B | 647.8B | 647.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | 45M | 25M | 69M | 18M |
Preferred stock dividends | 0 | 0 | 0 | 0 |